Last update 08 Jul 2025

Pemafibrate/Tofogliflozin Hydrate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
K-001
Target
PPARα x SGLT2
Action
agonists, inhibitors
Mechanism
PPARα agonists(Peroxisome proliferator-activated receptor α agonists), SGLT2 inhibitors(Sodium/glucose cotransporter 2 inhibitors)
Therapeutic Areas
Digestive System Disorders
Active Indication
Metabolic dysfunction-associated steatotic liver disease
Inactive Indication-
Originator Organization
Kowa Research Institute, Inc.
Active Organization
Kowa Co., Ltd.Kowa Co., Ltd.
Inactive Organization
Kowa Research Institute, Inc.
License Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC28H30N2O6
InChIKeyZHKNLJLMDFQVHJ-RUZDIDTESA-N
CAS Registry848259-27-8
View All Structures (2)

Related

1
Clinical Trials associated with Pemafibrate/Tofogliflozin Hydrate
NCT05722262
/ CompletedPhase 1
A Randomized, Open-Label, Six-Sequence, Three-Period Crossover Study to Demonstrate the Bioequivalence of Single Oral Administration of K-001 Relative to Single Oral Coadministration of Separate Tablets of K-877-ER Plus CSG452 in Healthy Adult Volunteers, and to Characterize the Food Effect on the Pharmacokinetics of K-001
100 Clinical Results associated with Pemafibrate/Tofogliflozin Hydrate
Login to view more data
100 Translational Medicine associated with Pemafibrate/Tofogliflozin Hydrate
Login to view more data
100 Patents (Medical) associated with Pemafibrate/Tofogliflozin Hydrate
Login to view more data
100 Deals associated with Pemafibrate/Tofogliflozin Hydrate
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Metabolic dysfunction-associated steatotic liver diseasePhase 2
United States
Kowa Co., Ltd.Kowa Co., Ltd.
-
Metabolic dysfunction-associated steatotic liver diseasePhase 2
Japan
Kowa Co., Ltd.Kowa Co., Ltd.
-
Metabolic dysfunction-associated steatotic liver diseasePhase 2
Spain
Kowa Co., Ltd.Kowa Co., Ltd.
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free